Spring til hovednavigation Spring til søgning Spring til hovedindhold

Duration of Deep Molecular Response" Has Most Impact on the Success of Cessation of Tyrosine Kinase Inhibitor Treatment in Chronic Myeloid Leukemia - Results from the EURO-SKI Trial

  • Susanne Saussele
  • , Johan Richter
  • , Joelle Guilhot
  • , Henrik Hjorth-Hansen
  • , Antonio Medina de Almeida
  • , Jeroen J. W. M. Janssen
  • , Jiri Mayer
  • , Perttu Koskenvesa
  • , Panayiotis Panayiotidis
  • , Ulla Olsson-Strömberg
  • , Juan Luis Steegmann
  • , Hanne Vestergaard
  • , Hans Ehrencrona
  • , Veli Kairisto
  • , Kateřina Machová Poláková
  • , Martin Müller
  • , Satu Mustjoki
  • , Marc G. Berger
  • , Philippe Rousselot
  • , Martine Escoffre-Barbe
  • Jolanta Dengler, Françoise Rigal-Huguet, Nikolas von Bubnoff, Hana Klamova, Edgar Faber, François Guilhot, Kourosh Lotfi, Delphine Rea, Tim H. Brümmendorf, Gorgine de Greef, Leif Stenke, Franck Emmanuel Nicolini, Laurence Legros, Andreas Burchert, Jaroslava Voglová, Aude Charbonnier, Emmanuel Gyan, Maria-Elisabeth Goebeler, Peter E. Westerweel, Andreas Hochhaus, Markus Pfirrmann, Francois-Xavier Francois-Xavier Mahon
  • Heidelberg University
  • INSERM CIC 1402, CHU de Poitiers, Poitiers, France
  • Skåne University Hospital
  • St. Olavs Hospital
  • VU University Medical Center
  • Oncology Institute Francisco Gentil
  • National and Kapodistrian University of Athens
  • University of Helsinki
  • Hospital La Princesa, Madrid, Spain.
  • Turku University Hospital
  • Institute of Hematology and Blood Transfusion, Prague, Czech Republic
  • Uppsala University Hospital
  • Institute for Hematology and Oncology (IHO GmbH), Mannheim, Germany
  • Hématologie Biologique and EA 7453 CHELTER, CHU Estaing and Université Clermont Auvergne
  • Department of Hematology and Oncology, Centre Hospitalier de Versailles, INSERM UMR 1173, Université Versailles Saint-Quentin-en-Yvelines, Université Paris Saclay, Le Chesnay, France
  • Hôpital de Versailles, Le Chesnay, France
  • Fi-LMC group, Pessac, France
  • Onkologische Schwerpunktpraxis Heilbronn, Heilbronn, Germany
  • Toulouse University Hospital
  • University Medical Center Freiburg
  • Rennes University Hospital
  • Palacký University Olomouc
  • Linköping University
  • Saint-Louis Hospital
  • RWTH Aachen University
  • Erasmus University Medical Center Rotterdam
  • Karolinska Institutet
  • The Léon Bérard Cancer Center
  • Lyon Sud Hospital Center
  • Centre de Recherche en Cancérologie de Lyon
  • CHU Nice
  • Klinik für Innere Medizin, Schwerpunkt Hämatologie, Onkologie und Immunologie, Universitätsklinikum Marburg, Marburg, Germany
  • Charles University
  • Paoli-Calmettes Institute
  • Hématologie et Thérapie Cellulaire, CHU de Tours, Tours, France
  • Medizinische Klinik und Poliklinik, Universitätsklinikum Würzburg, Würzburg, Germany
  • Albert Schweitzer Hospital
  • Jena University Hospital
  • Ludwig-Maximilian University of Munich
  • University of Bordeaux
  • Masaryk University
  • University Hospital Brno

Publikation: Konferencebidrag uden forlag/tidsskriftKonferenceabstrakt til konferenceForskningpeer review

OriginalsprogEngelsk
Publikationsdato10. dec. 2017
StatusUdgivet - 10. dec. 2017
Begivenhed59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 
 - Atlanta, USA
Varighed: 9. dec. 201712. dec. 2017

Konference

Konference59th Annual Meeting and Exposition of the American Society of Hematology December 9-12th 2017, Atlanta, USA 

Land/OmrådeUSA
ByAtlanta
Periode09/12/201712/12/2017

Citationsformater